These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22739979)

  • 21. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse-coordinated care in CKD: time for translation into practice?
    Smith DH; Thorp ML
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1229-31. PubMed ID: 21617089
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
    Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.
    Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW
    Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
    Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Searching for new care models for chronic kidney disease.
    Shah AP; Mehrotra R
    Kidney Int; 2012 Sep; 82(6):621-3. PubMed ID: 22935879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.
    Hung SC; Lai YS; Kuo KL; Tarng DC
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
    N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
    Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
    Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
    Iimori S; Naito S; Noda Y; Nishida H; Kihira H; Yui N; Okado T; Sasaki S; Uchida S; Rai T
    Nephrology (Carlton); 2015 Sep; 20(9):601-8. PubMed ID: 25917812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.
    Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
    Tohoku J Exp Med; 2017 Aug; 242(4):281-290. PubMed ID: 28824047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
    Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
    Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes.
    Ovbiagele B; Schwamm LH; Smith EE; Grau-Sepulveda MV; Saver JL; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2265-73. PubMed ID: 25158677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidants for chronic kidney disease.
    Jun M
    Nephrology (Carlton); 2013 Aug; 18(8):576-8. PubMed ID: 23865542
    [No Abstract]   [Full Text] [Related]  

  • 39. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
    Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.